Testing effectiveness (Phase 2)Ended earlyNCT02094560
What this trial is testing
CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors
Who this might be right for
Advanced Endstage Solid Carcinomas in Adults
CellAct Pharma GmbH 45